{"id":"https://openalex.org/W7222531703","doi":"https://doi.org/10.1200/po-26-00484","title":"PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study","display_name":"PIK3CA Mutations in Advanced or Recurrent Endometrial Cancer: An Exploratory Molecular Profiling From the Phase II MITO END-3 Study","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7222531703","doi":"https://doi.org/10.1200/po-26-00484","pmid":"https://pubmed.ncbi.nlm.nih.gov/42886889","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13704708"},"language":"en","primary_location":{"id":"doi:10.1200/po-26-00484","doi":"https://doi.org/10.1200/po-26-00484","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po-26-00484","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO-26-00484","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO-26-00484","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019738500","display_name":"Anna Maria Passarelli","orcid":"https://orcid.org/0000-0003-4643-7809","observed_orcids":["https://orcid.org/0000-0003-4643-7809"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Anna Passarelli","raw_affiliation_strings":["Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0003-4643-7809","affiliations":[{"raw_affiliation_string":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090921040","display_name":"Giovanni Luca Scaglione","orcid":"https://orcid.org/0000-0001-5622-7843","observed_orcids":["https://orcid.org/0000-0001-5622-7843"]},"institutions":[{"id":"https://openalex.org/I4210116004","display_name":"Istituto Dermopatico dell'Immacolata","ror":"https://ror.org/02b5mfy68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210116004","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Luca Scaglione","raw_affiliation_strings":["Bioinformatics Unit, Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy"],"raw_orcid":"https://orcid.org/0000-0001-5622-7843","affiliations":[{"raw_affiliation_string":"Bioinformatics Unit, Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I4210116004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040899290","display_name":"Daniela Califano","orcid":"https://orcid.org/0000-0001-6945-3209","observed_orcids":["https://orcid.org/0000-0001-6945-3209"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniela Califano","raw_affiliation_strings":["Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0001-6945-3209","affiliations":[{"raw_affiliation_string":"Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039767477","display_name":"Michele Bartoletti","orcid":"https://orcid.org/0000-0002-9631-5693","observed_orcids":["https://orcid.org/0000-0002-9631-5693"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Michele Bartoletti","raw_affiliation_strings":["Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy"],"raw_orcid":"https://orcid.org/0000-0002-9631-5693","affiliations":[{"raw_affiliation_string":"Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061939825","display_name":"Domenica Lorusso","orcid":"https://orcid.org/0000-0003-0981-0598","observed_orcids":["https://orcid.org/0000-0003-0981-0598"]},"institutions":[{"id":"https://openalex.org/I1339471597","display_name":"Humanitas University","ror":"https://ror.org/020dggs04","country_code":"IT","type":"education","lineage":["https://openalex.org/I1339471597"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Domenica Lorusso","raw_affiliation_strings":["Department of Biomedical Sciences, Humanitas University, Milan, Italy","Division of Gynecologic Oncology, Humanitas San Pio X, Milan, Italy"],"raw_orcid":"https://orcid.org/0000-0003-0981-0598","affiliations":[{"raw_affiliation_string":"Department of Biomedical Sciences, Humanitas University, Milan, Italy","institution_ids":["https://openalex.org/I1339471597"]},{"raw_affiliation_string":"Division of Gynecologic Oncology, Humanitas San Pio X, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044888208","display_name":"Sabrina Chiara Cecere","orcid":"https://orcid.org/0000-0002-7915-1623","observed_orcids":["https://orcid.org/0000-0002-7915-1623"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sabrina Chiara Cecere","raw_affiliation_strings":["Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076497986","display_name":"Anna Fagotti","orcid":"https://orcid.org/0000-0001-5579-335X","observed_orcids":["https://orcid.org/0000-0001-5579-335X","https://orcid.org/0000-0003-0223-2377","https://orcid.org/0000-0002-0465-5990"]},"institutions":[{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Fagotti","raw_affiliation_strings":["Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy"],"raw_orcid":"https://orcid.org/0000-0001-5579-335X","affiliations":[{"raw_affiliation_string":"Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I2802557943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006629788","display_name":"Alberto Farolfi","orcid":"https://orcid.org/0000-0002-3289-8041","observed_orcids":["https://orcid.org/0000-0002-3289-8041"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alberto Farolfi","raw_affiliation_strings":["Medical Oncology, Breast &amp; GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Meldola, Italy"],"raw_orcid":"https://orcid.org/0000-0002-3289-8041","affiliations":[{"raw_affiliation_string":"Medical Oncology, Breast &amp; GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, Meldola, Italy","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066280513","display_name":"Claudia Andreetta","orcid":"https://orcid.org/0000-0002-0470-043X","observed_orcids":["https://orcid.org/0000-0002-0470-043X"]},"institutions":[{"id":"https://openalex.org/I4210126152","display_name":"Ospedale Santa Maria della Misericordia di Udine","ror":"https://ror.org/02zpc2253","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210126152"]},{"id":"https://openalex.org/I4405267403","display_name":"Azienda sanitaria universitaria Friuli Centrale","ror":"https://ror.org/02kmqc238","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4405267403"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudia Andreetta","raw_affiliation_strings":["Department of Medical Oncology, \u201cS. Maria della Misericordia\u201d University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy"],"raw_orcid":"https://orcid.org/0000-0002-0470-043X","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, \u201cS. Maria della Misericordia\u201d University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy","institution_ids":["https://openalex.org/I4210126152","https://openalex.org/I4405267403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019880542","display_name":"Jole Ventriglia","orcid":"https://orcid.org/0000-0002-8160-5014","observed_orcids":["https://orcid.org/0000-0002-8160-5014"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Jole Ventriglia","raw_affiliation_strings":["Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023024840","display_name":"Laura Arenare","orcid":"https://orcid.org/0000-0001-7100-4517","observed_orcids":["https://orcid.org/0000-0001-7100-4517"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Arenare","raw_affiliation_strings":["Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030595144","display_name":"Carmela Pisano","orcid":"https://orcid.org/0000-0003-4577-6534","observed_orcids":["https://orcid.org/0000-0003-4577-6534"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carmela Pisano","raw_affiliation_strings":["Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079704027","display_name":"Daniela Russo","orcid":"https://orcid.org/0000-0001-9471-1935","observed_orcids":["https://orcid.org/0000-0001-9471-1935"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniela Russo","raw_affiliation_strings":["Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006723870","display_name":"Maria Teresa Perri","orcid":"https://orcid.org/0000-0002-0222-656X","observed_orcids":["https://orcid.org/0000-0002-0222-656X"]},"institutions":[{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Teresa Perri","raw_affiliation_strings":["Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I2802557943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111207751","display_name":"Saverio Cinieri","orcid":"https://orcid.org/0009-0009-1440-7278","observed_orcids":["https://orcid.org/0009-0009-1440-7278"]},"institutions":[{"id":"https://openalex.org/I4210103648","display_name":"Ospedale A. Perrino","ror":"https://ror.org/01ae87070","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210099368","https://openalex.org/I4210103648","https://openalex.org/I4210117053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Saverio Cinieri","raw_affiliation_strings":["U.O.C. Oncologia Medica-Ospedale Senatore Antonio Perrino, Brindisi, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"U.O.C. Oncologia Medica-Ospedale Senatore Antonio Perrino, Brindisi, Italy","institution_ids":["https://openalex.org/I4210103648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075663363","display_name":"Simona Scalone","orcid":"https://orcid.org/0000-0002-4647-0919","observed_orcids":["https://orcid.org/0000-0002-4647-0919"]},"institutions":[{"id":"https://openalex.org/I4210128630","display_name":"Centro di Riferimento Oncologico","ror":"https://ror.org/03ks1vk59","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210128630","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Simona Scalone","raw_affiliation_strings":["Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy","institution_ids":["https://openalex.org/I4210128630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071060598","display_name":"Ugo De Giorgi","orcid":"https://orcid.org/0000-0001-7520-2908","observed_orcids":["https://orcid.org/0000-0001-7520-2908"]},"institutions":[{"id":"https://openalex.org/I142910587","display_name":"University of Salento","ror":"https://ror.org/03fc1k060","country_code":"IT","type":"education","lineage":["https://openalex.org/I142910587"]},{"id":"https://openalex.org/I4210152598","display_name":"Ospedale Vito Fazzi","ror":"https://ror.org/04fvmv716","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210099368","https://openalex.org/I4210117053","https://openalex.org/I4210152598"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ugo De Giorgi","raw_affiliation_strings":["Department of Experimental Medicine, University of Salento, Fazzi Hospital, Lecce, Italy"],"raw_orcid":"https://orcid.org/0000-0001-7520-2908","affiliations":[{"raw_affiliation_string":"Department of Experimental Medicine, University of Salento, Fazzi Hospital, Lecce, Italy","institution_ids":["https://openalex.org/I142910587","https://openalex.org/I4210152598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023897998","display_name":"Valentina Arcangeli","orcid":"https://orcid.org/0000-0001-6866-2957","observed_orcids":["https://orcid.org/0000-0001-6866-2957"]},"institutions":[{"id":"https://openalex.org/I4210097834","display_name":"Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori","ror":"https://ror.org/013wkc921","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210097834","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Valentina Arcangeli","raw_affiliation_strings":["Romagna Cancer Registry IRCCS Istituto Romagnolo per lo Studio dei Tumori \u201cDino Amadori\u201d (IRST), Meldola, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Romagna Cancer Registry IRCCS Istituto Romagnolo per lo Studio dei Tumori \u201cDino Amadori\u201d (IRST), Meldola, Italy","institution_ids":["https://openalex.org/I4210097834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024385179","display_name":"Elena Zafarana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210156604","display_name":"Azienda Usl Toscana Centro","ror":"https://ror.org/05a87zb20","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210156604"]},{"id":"https://openalex.org/I4210166882","display_name":"Hospital of Prato","ror":"https://ror.org/03gbp6p96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210156494","https://openalex.org/I4210156604","https://openalex.org/I4210166882"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Zafarana","raw_affiliation_strings":["Department of Oncology, Hospital of Prato Azienda USL Toscana Centro, Prato, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Hospital of Prato Azienda USL Toscana Centro, Prato, Italy","institution_ids":["https://openalex.org/I4210156604","https://openalex.org/I4210166882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002347213","display_name":"Maria Chiara Cannizzaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802557943","display_name":"Agostino Gemelli University Polyclinic","ror":"https://ror.org/00rg70c39","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2802557943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Chiara Cannizzaro","raw_affiliation_strings":["Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento Scienze della Salute della Donna, del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy","institution_ids":["https://openalex.org/I2802557943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065723799","display_name":"Serafina Mammoliti","orcid":"https://orcid.org/0000-0002-6560-0061","observed_orcids":["https://orcid.org/0000-0002-6560-0061"]},"institutions":[{"id":"https://openalex.org/I4405264730","display_name":"IRCCS Azienda Ospedaliera Metropolitana","ror":"https://ror.org/02skabv63","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Serafina Mammoliti","raw_affiliation_strings":["AOM Liguria, Azienda Ospedaliera Metropolitana di Genova, Genoa, Italy"],"raw_orcid":"https://orcid.org/0000-0002-6560-0061","affiliations":[{"raw_affiliation_string":"AOM Liguria, Azienda Ospedaliera Metropolitana di Genova, Genoa, Italy","institution_ids":["https://openalex.org/I4405264730"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158921421","display_name":"Tommaso Ambrosio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Tommaso Ambrosio","raw_affiliation_strings":["Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058808068","display_name":"Rossella De Cecio","orcid":"https://orcid.org/0000-0001-9779-7076","observed_orcids":["https://orcid.org/0000-0001-9779-7076"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rossella De Cecio","raw_affiliation_strings":["Division of Anatomic Pathology and Cytopathology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Anatomic Pathology and Cytopathology, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055316467","display_name":"Clorinda Schettino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Clorinda Schettino","raw_affiliation_strings":["Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102804100","display_name":"Francesco Perrone","orcid":"https://orcid.org/0000-0002-9738-0526","observed_orcids":["https://orcid.org/0000-0002-9738-0526"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Perrone","raw_affiliation_strings":["Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0002-9738-0526","affiliations":[{"raw_affiliation_string":"Clinical Trial Unit, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083659627","display_name":"Sandro Pignata","orcid":"https://orcid.org/0000-0002-8836-2633","observed_orcids":["https://orcid.org/0000-0002-8836-2633"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sandro Pignata","raw_affiliation_strings":["Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy"],"raw_orcid":"https://orcid.org/0000-0002-8836-2633","affiliations":[{"raw_affiliation_string":"Uro-Gynecological Medical Oncology, Istituto Nazionale Tumori\u2014IRCCS\u2014Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5019738500"],"corresponding_institution_ids":["https://openalex.org/I4210141868"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82362827,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"10","first_page":"e2600484","last_page":"e2600484"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.5746999979019165,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.5746999979019165,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.35690000653266907,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9950000047683716},{"id":"https://openalex.org/keywords/endometrial-cancer","display_name":"endometrial cancer","score":0.8980000019073486},{"id":"https://openalex.org/keywords/recurrent-endometrial-cancer","display_name":"recurrent endometrial cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/alpelisib","display_name":"alpelisib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/molecular-profiling","display_name":"molecular profiling","score":0.5600000023841858},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.7730000019073486},{"id":"https://openalex.org/keywords/arid1a","display_name":"ARID1A","score":0.984000027179718},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":1.0},{"id":"https://openalex.org/keywords/microsatellite-instability-high","display_name":"microsatellite instability-high","score":0.7630000114440918},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6520000100135803},{"id":"https://openalex.org/keywords/kinase-domain-mutations","display_name":"kinase domain mutations","score":0.6880000233650208},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7509999871253967}],"concepts":[{"id":"https://openalex.org/C2781273526","wikidata":"https://www.wikidata.org/wiki/Q18032797","display_name":"ARID1A","level":4,"score":0.5644000172615051},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5194000005722046},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.44850000739097595},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.41679999232292175},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.39910000562667847},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.39160001277923584},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39100000262260437},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.3874000012874603},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38510000705718994},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.3828999996185303},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37779998779296875},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.33399999141693115},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.33320000767707825},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3330000042915344},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.32710000872612},{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.3237000107765198},{"id":"https://openalex.org/C24432333","wikidata":"https://www.wikidata.org/wiki/Q2068526","display_name":"Whole genome sequencing","level":4,"score":0.32249999046325684},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.31779998540878296},{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.3174999952316284},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3149000108242035},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.31029999256134033},{"id":"https://openalex.org/C51679486","wikidata":"https://www.wikidata.org/wiki/Q380546","display_name":"DNA sequencing","level":3,"score":0.3100000023841858},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3075999915599823},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30480000376701355},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.3012999892234802},{"id":"https://openalex.org/C163565370","wikidata":"https://www.wikidata.org/wiki/Q4308623","display_name":"Mutation testing","level":4,"score":0.29429998993873596},{"id":"https://openalex.org/C61053724","wikidata":"https://www.wikidata.org/wiki/Q1154615","display_name":"Sequence analysis","level":3,"score":0.28839999437332153},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2822999954223633},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.2685000002384186},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2615000009536743},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.25200000405311584}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D059014","descriptor_name":"High-Throughput Nucleotide Sequencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/po-26-00484","doi":"https://doi.org/10.1200/po-26-00484","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po-26-00484","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO-26-00484","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13704708","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13704708/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13704708/pdf/po-10-e2600484.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precis Oncol","raw_type":"Text"},{"id":"pmid:42886889","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42886889","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO precision oncology","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1200/po-26-00484","doi":"https://doi.org/10.1200/po-26-00484","is_oa":true,"landing_page_url":"https://doi.org/10.1200/po-26-00484","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/PO-26-00484","source":{"id":"https://openalex.org/S4210227748","display_name":"JCO Precision Oncology","issn_l":"2473-4284","issn":["2473-4284"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Precision Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320312140","display_name":"Exelixis","ror":"https://ror.org/01e3jga91"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7222531703.pdf","grobid_xml":"https://content.openalex.org/works/W7222531703.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1977660708","https://openalex.org/W2023898364","https://openalex.org/W2041440766","https://openalex.org/W2044869180","https://openalex.org/W2067040565","https://openalex.org/W2071591166","https://openalex.org/W2152654745","https://openalex.org/W2154893943","https://openalex.org/W2157079036","https://openalex.org/W2303306419","https://openalex.org/W2597420951","https://openalex.org/W2751685080","https://openalex.org/W2786945112","https://openalex.org/W2789281724","https://openalex.org/W2793677489","https://openalex.org/W2945564879","https://openalex.org/W2997415922","https://openalex.org/W3005541608","https://openalex.org/W3047152751","https://openalex.org/W3114074286","https://openalex.org/W3128646645","https://openalex.org/W3141372695","https://openalex.org/W4206897023","https://openalex.org/W4315864360","https://openalex.org/W4320716053","https://openalex.org/W4378801565","https://openalex.org/W4393029256","https://openalex.org/W4396621269","https://openalex.org/W4403912600","https://openalex.org/W4404450071","https://openalex.org/W4413949470","https://openalex.org/W4417041953"],"related_works":["https://openalex.org/W7154991085","https://openalex.org/W4315864360","https://openalex.org/W4411643044","https://openalex.org/W2011028703","https://openalex.org/W2165992619","https://openalex.org/W2904334146","https://openalex.org/W7202033630","https://openalex.org/W2772844454","https://openalex.org/W1983499779","https://openalex.org/W2999134062"],"abstract_inverted_index":{"Purpose":[0],"Immunotherapy":[1],"with":[2,71,81,142,202],"chemotherapy":[3],"significantly":[4],"improves":[5],"progression-free":[6],"survival":[7],"in":[8,14,24,40,111,150,160,172,191,208,216,242,256],"advanced":[9],"endometrial":[10],"cancer":[11],"(EC),":[12],"especially":[13],"microsatellite":[15],"instability-high":[16],"(MSI-H)":[17],"cases.":[18],"Despite":[19],"this,":[20],"for":[21,74,251],"recurrent":[22],"EC":[23],"the":[25,59,65,92,143,161,173,230,236],"postimmunotherapy":[26],"setting,":[27],"new":[28],"treatment":[29,48],"options":[30],"are":[31,194],"urgently":[32],"needed.":[33],"The":[34,153,218],"PI3K":[35,200,254],"pathway":[36],"is":[37],"frequently":[38,95],"altered":[39],"gynecologic":[41],"cancers,":[42],"including":[43,176],"EC,":[44,243],"representing":[45],"a":[46,54,82],"potential":[47],"target.":[49],"Patients":[50],"and":[51,105,133,168,171,179],"Methods":[52],"In":[53,89,224],"preplanned":[55],"translational":[56],"analysis":[57,78,228],"of":[58,68,115,120,127,139,145,188,197,239,253],"MITO":[60,192,231],"END-3,":[61],"we":[62,234],"retrospectively":[63],"analyzed":[64],"genomic":[66],"abnormalities":[67],"107":[69],"patients":[70],"samples":[72],"eligible":[73],"next-generation":[75],"sequencing":[76],"(NGS)":[77],"(FoundationOne":[79],"CDx)":[80],"focus":[83],"on":[84],"PIK3CA":[85,101,107,123,156,185,212,240],"mutational":[86],"status.":[87],"Results":[88],"our":[90],"analysis,":[91],"four":[93,134],"most":[94,154,164],"mutated":[96],"genes":[97],"were":[98,109,125,130,135,158,214],"TP53":[99],",":[100,102,104],"ARID1A":[103],"PTEN.":[106],"mutations":[108,124,149,157,186,213,241],"detected":[110],"51.4%":[112],"(55/107":[113],"patients)":[114],"tissue":[116],"samples.":[117],"A":[118],"total":[119],"68":[121,189],"different":[122,147,184],"observed,":[126],"which":[128],"64":[129],"considered":[131,195],"pathogenic":[132,148],"classified":[136],"as":[137,247],"variants":[138],"unknown":[140],"significance,":[141],"co-occurrence":[144],"two":[146],"2":[151],"patients.":[152],"frequent":[155],"found":[159],"kinase":[162],"domain,":[163,175],"commonly":[165],"H1047R":[166],"(11/68)":[167],"H1047Y":[169],"(3/68),":[170],"helical":[174],"E545K":[177],"(4/68)":[178],"E542K":[180],"(3/68).":[181],"Notably,":[182],"24":[183],"out":[187],"reported":[190],"END-3":[193,232],"predictive":[196],"response":[198],"to":[199,205],"inhibition":[201],"alpelisib":[203],"according":[204],"current":[206],"literature":[207],"breast":[209],"cancer.":[210],"Interestingly,":[211],"observed":[215],"all":[217],"Cancer":[219],"Genome":[220],"Atlas":[221],"categories.":[222],"Conclusion":[223],"this":[225,245],"post":[226],"hoc":[227],"from":[229],"trial,":[233],"confirmed":[235],"high":[237],"frequency":[238],"establishing":[244],"tumor":[246],"an":[248],"ideal":[249],"candidate":[250],"testing":[252],"inhibitors":[255],"clinical":[257],"trials.":[258]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-10-17T00:00:00"}
